Radical Cystectomy for MIBC Offers Better Survival vs Chemoradiation
Large study reveals a significant 15% survival advantage associated with radical cystectomy vs chemoradiation therapy.
Large study reveals a significant 15% survival advantage associated with radical cystectomy vs chemoradiation therapy.
In a study, initial treatment with ketorolac vs an opioid was associated with a shorter stay in the emergency department and lower likelihood of hospital admission.
Researchers are scheduled to present more than 2500 studies at the American Urological Association 2018 annual meeting in San Francisco.